 |
We
see
two
nice
runs
in
Ford
that
ARM2
picked
up,
beginning
with
the
stellar
Short
in
late
January 2003 and ending with the equally
fabulous Long in April. |
 |
Genencor
shows
two
nice
ARM2
signals
in
January 2003
(Long)
and
February (Short). |
 |
Grey
Wolf
is
another
volatile
stock,
but
we
did
see
some
nice
ARM2
signals
generated
on
it. |
 |
IDEC
Pharmaceuticals
had
a
great
Short
signals
in
late
January 2003,
after
an
exhaustion
gap. |
 |
IONA Technologies is a smooth moving stock,
even through it was
trading
around
$1.00. |
 |
IMPAX
Labs
had
two
nice
Longs,
one
in
January 2003
and
the
next
in
March.
|
 |
Iron Mountain had several swings in the
beginning of the year, all of which were
identified by ARM2 R3. |
 |
Lexicon
Genetics
had
several
nice
moves.
The
Long
in
mid
December
2002 was
particularly
potent. Note this stock declining in
February while the previous stock (IRM)
increasing in the same time period. We
saw ARM2 R3 signals fire on both, in the
correct directions.
This is one of
the powerful things about our ARM technology -
it allows us to diversify across multiple
stocks by trading ARM Signals in both
directions. |
 |
Longview
generated
an
interesting,
smooth
chart
after
the
Sell
signal
in
mid
January,
leading
up
to
the
Buy
in
mid
March 2003.
Because
this
stock
is
so
low
priced,
both
signals
generated
huge
returns. |
 |
Three
nice
Shorts
on
Moore
Ltd.,
with
a
new
Long
on
the
right
side
of
the
chart. |
 |
Again,
this
is
the
kind
of
stock
we
are
looking
to
trade
-
nice
clean
moves.
Each
signal
on
this
page
generated
10%
or
more,
with
clean
exit
points
due
to
the
smooth
nature
of
99
Cents
Only
stores. |
 |
Northrop has become volatile recently, but
shows several nice ARM2 signals over a 5 month
period. |
 |
Newpark
is
another
volatile
stock,
but
we
had
a
relatively
clean
Long
signal
generated
at
the
lows
in
February 2003. |
 |
Nextel
is a
beautiful
trading
range
stock.
Note
the
swings,
up
and
down,
beginning
January 2003. Each was properly
identified by ARM2 Release 3. |
 |
We
see
a
near
perfect
V-bottom
signal
on
ONYX
Pharmaceuticals
in
early
February 2003,
following
two
clear
Short
opportunities. |
